Abstract
Background Health care workers (HCWs) need to perform new preventive measures to protect themselves and patients against ongoing COVID-19 transmission, which can increase the occurrence of hand dermatitis (HD) among them.
Objectives This study aimed to investigate the prevalence of HD among HCWs and its possible risk factors in IRAN.
Methods A survey of 159 HCWS working in university hospitals was performed between August to September 2020. Research data were collected via the standardized Nordic Occupational Skin Questionnaire (NOSQ-2002).
Results The prevalence of HD in the study population was 51.6%. Females had a 3.84 fold higher risk of HD than males (confidence interval (CI): 1.85-8). HCWs older than 40 years and those who aged 30-39 years had a 9.6 and 1.72 fold higher risk of HD than HCWs aged 20-29 years (CI: 2.6-35.7; CI: 0.87-3.4, respectively). A significant association was found between the prevalence of HD among HCWs and working hours per week, and wearing gloves (P<0.05).
Conclusion Possible risk factors for developing HD among HCWs are female gender and older age. Preventive measures for HD are needed for HCWs, especially during the COVID- 19 pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
the research ethics committee on Research Ethics at Birjand University of Medical Sciences approved code: 3789 ethics code: ir.bums.REC.1398.8
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors